NCT07531121Active, not recruiting
ctDNA for Risk Stratification in Melanoma
The Value of Circulating Tumour DNA in Risk Stratification in Melanoma
Source: ClinicalTrials.gov · Last updated 15 Apr 2026
Brief summary (registry, in English)
This study examines circulating tumor DNA (ctDNA) as a biomarker in patients with primary melanoma, prior to surgical excision. The hypothesis is that ctDNA may be detectable in pre-operative blood samples from patients with high-risk primary melanoma, potentially providing a baseline measurement for future disease monitoring.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 296 (actual)
- First submitted
- 31 Mar 2026
- Start date
- 10 Sept 2021
- Primary completion date
- 20 May 2025
- Lead sponsor
- Herlev and Gentofte Hospital
- Diseases
- Melanoma
- NCT number
- NCT07531121
What you commit to
- Study type: Observational
- Participants enrolled: 296
- From 10 Sept 2021 to the primary completion date, 20 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age less than 18 years
Other
- Pregnancy
- Inability to provide written informed consent
Who the study is looking for
- Age 18 years or older
- Clinical suspicion of primary cutaneous melanoma
- Presenting at the Department of Plastic and Reconstructive Surgery, Herlev and Gentofte University Hospital
- Able to provide written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dept. of Plastic and Reconstructive Surgery, Herlev and Gentofte University Hospital Coordinator of this site? Confirm its status | Herlev | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.